Future in Healthcare
The image and reputation of healthcare has room for improvement, as it is often characterized by mediocre quality, exorbitant costs, poor safety and inadequate patient-centeredness.
Never have these shortcomings been more visible than during the Covid-19 pandemic, when it became clear that rebooting the system is of paramount importance.
​
Despite considerable variations in healthcare systems around the world, most countries suffer from similar limitations and gaps. Preventable harm to patients, failure to provide care that is focused on patients' needs and expectations, neglecting the importance of health-related quality of life measures and overall function, disregarding the effects of prevention, and last but not least, the total elusion of economic sustainability, are just some of the characteristics that mark modern healthcare systems.
​
Rapid transformation is therefore of utmost importance, and the following drivers of change are recognized as the ones that might revolutionize healthcare within the next decade:
The future in healthcare will consequently manifest itself in fundamental transformations of the following capabilities in healthcare:
Healthcare systems, if unprepared to find solutions for these challenges, will inevitably face setbacks and losses in the provision of healthcare quality.
​
This reality will finally end up in crucial inefficiencies, dissatisfaction among healthcare providers and patients, but also among payers, who will keep having doubts in the value for money in medicines. This may then result in stringent cost-control measures, which will consequently bring to a downfall of quality in care, which will turn off the money tap, and so on and so on.
To escape from this vicious circle, all stakeholders will need to invest in innovations and focus on personalized healthcare.
​
The "one size fits all" mentality in healthcare has reached rock bottom.
The focus on rare diseases and oncology have made it clear that treatment approaches need to focus on the individual constitution of a patient, his or her own genetic signature.
And now it becomes clear as day why the old-fashioned disease-centric approach worked well for one patient, but did not work for another one with the same disease.
It took decades to understand, that the old scattergun approach in healthcare is leading healthcare systems into a wasteful resource allocation, literally throwing out money from the window.
​
Therefore patient-centric approaches, and their concomitantly necessary investments in technological innovations, have the potential to increase the treatment efficacy and quality, may provide better value for money and will at the end increase the satisfaction of all stakeholders involved.
​
We support our clients in every aspect of pharmaceutical excellence, including product strategy, process transformation and capability enhancement.
​
This means harnessing available data sources, utilization of digital platforms, navigation through a changing Payer & Reimbursement landscape and collaboration with academic centers and patient organizations, in order to demonstrate value to decision-making audiences.
​
In addition, by focusing on emerging new technologies and analytics, which are driving change throughout the pharma industry value chain, we will support you strengthen your competitive position to better meet the changing needs of your audiences.